Nature de la demande
Réévaluation du SMR
Service Médical Rendu (SMR)
| Faible |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
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
5GJTRv12bttMRuyc
Écouter
